Medical Innovation Exchange

Pharvaris to embark on 6-month tox test in hopes of reversing US clinical hold for HAE asset

https://www.fiercebiotech.com/biotech/pharvaris-embark-six-month-tox-test-hopes-reversing-us-clinical-hold-lifted-hae-asset

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!